Alex Goddard joined AOBiome in 2018 as VP of Research and Development. Alex brings a wealth of experience in strategy and execution. He has worked to progress therapeutics spanning pharmaceutical, device, and digital health approaches, with previous positions at Novartis, Tal Medical, and Sync Project. His areas of scientific expertise include neuron-immune interactions, neurological and psychiatric disease, and ammonia-oxidizing bacteria.
Dr. Goddard received bachelor’s degrees in Neuroscience and in Biochemistry from Oberlin College, his Ph.D. in Neurobiology from Harvard University, and did his postdoctoral work at Stanford University. He has authored numerous scientific publications. He is also a doting father, an avid musician, and a tolerable cook.